Matches in Wikidata for { <http://www.wikidata.org/entity/Q91274335> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q91274335 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q91274335 description "scientific article published on 29 January 2019" @default.
- Q91274335 description "wetenschappelijk artikel" @default.
- Q91274335 description "наукова стаття, опублікована 29 січня 2019" @default.
- Q91274335 name "Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment" @default.
- Q91274335 name "Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment" @default.
- Q91274335 type Item @default.
- Q91274335 label "Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment" @default.
- Q91274335 label "Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment" @default.
- Q91274335 prefLabel "Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment" @default.
- Q91274335 prefLabel "Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment" @default.
- Q91274335 P1433 Q91274335-5B6027F4-D90A-489D-9967-C20A446EB589 @default.
- Q91274335 P1476 Q91274335-2770F84F-F358-47F1-8A15-267CFB81204E @default.
- Q91274335 P2093 Q91274335-1A9D11B7-FB8D-405D-933B-A0F4DE239081 @default.
- Q91274335 P2093 Q91274335-5E217458-EDC9-4780-A67C-58784E5DA4F2 @default.
- Q91274335 P2093 Q91274335-B5C5C283-CE37-4BFB-9485-C979C4C79125 @default.
- Q91274335 P2093 Q91274335-F7932AD3-2659-4209-970D-3E4AB9DE09AB @default.
- Q91274335 P2860 Q91274335-A68828EF-D479-4DA7-98F5-85A25A7ACE48 @default.
- Q91274335 P31 Q91274335-D7EC1B93-0482-493B-B55B-6D1F3EE49054 @default.
- Q91274335 P356 Q91274335-B3CB6A88-D5D9-4EC0-8C57-B68427C9D34A @default.
- Q91274335 P50 Q91274335-91AACB04-C74D-46E0-B848-62DC6B530AF5 @default.
- Q91274335 P50 Q91274335-BF8A8834-B860-4C3E-A9AD-4DDD36A928E6 @default.
- Q91274335 P50 Q91274335-C64BDE7A-C1B5-4EB0-9B2D-6C5AC990BE93 @default.
- Q91274335 P577 Q91274335-3A5828FF-C157-4888-B769-B5870E96986D @default.
- Q91274335 P698 Q91274335-CA53A594-272C-43E0-94B3-1182453B6E7F @default.
- Q91274335 P356 JCP.28230 @default.
- Q91274335 P698 30697744 @default.
- Q91274335 P1433 Q1524270 @default.
- Q91274335 P1476 "Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment" @default.
- Q91274335 P2093 "Jamshid Gholizadeh Navashenaq" @default.
- Q91274335 P2093 "Maryam Ebrahimi Nik" @default.
- Q91274335 P2093 "Mehrdad Iranshahi" @default.
- Q91274335 P2093 "Parvin Zamani" @default.
- Q91274335 P2860 Q105151649 @default.
- Q91274335 P31 Q13442814 @default.
- Q91274335 P356 "10.1002/JCP.28230" @default.
- Q91274335 P50 Q47139696 @default.
- Q91274335 P50 Q57032972 @default.
- Q91274335 P50 Q57638207 @default.
- Q91274335 P577 "2019-01-29T00:00:00Z" @default.
- Q91274335 P698 "30697744" @default.